David Andreu News Today

 E-Mail Six innovative projects at UPF will receive funding and support for their development thanks to the knowledge transfer promotion programme UPF INNOValora. The UPF Business Shuttle-Innovation Unit has published the selected projects for a new edition of this programme organised to help promising technologies and knowledge generated by university research reach the production phase. Three of the selected projects come from the Department of Experimental and Health Sciences (DCEXS), while...

N international team, led by researchers from UPF David Andreu and Rafael Maldonado, has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects.

New peptides allow cannabis-derived drugs to fight pain in mice without side effects An international team, led by researchers from Pompeu Fabra University (UPF) in Barcelona, Spain, David Andreu and Rafael Maldonado, has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects. The study, published in the Journal of Medicinal Chemistry, was carried out together with researchers from the Autono...

New peptide could allow cannabis to fight pain without side effects Many people live with chronic pain, and in some cases, cannabis can provide relief. But the drug also can significantly impact memory and other cognitive functions. Now, researchers reporting in ACS Journal of Medicinal Chemistry have developed a peptide that, in mice, allowed Δ 9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain without the side effects. According to the U.S. Centers for Disea...